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Acute Ethanol Exposure Fails to Elicit
Preconditioning-Like Protection in
In Situ Rabbit Hearts Because of Its
Continued Presence During Ischemia
We read the findings of Krenz et al. (1) with great interest. Ischemic
preconditioning remains one intriguing explanation for the associa-
tion of moderate alcohol consumption with lower coronary mortality
(2) and lower case-fatality rate of acute myocardial infarction (MI) (3).
Their finding that the continued presence of ethanol during ischemia
eliminates its preconditioning effect may have important clinical
implications. We previously reported that alcohol use less than 6 h
before acute MI was not associated with a change in peak creatine
kinase level or risk of Q-wave infarction among patients enrolled in
the Determinants of Myocardial Infarction Onset Study (4), consis-
tent with their findings. Interestingly, we found 21% lower peak
creatine kinase levels and 23% lower odds of Q-wave infarction
among patients whose last alcohol consumption occurred 6 to 12 h
prior to infarction, although neither finding reached statistical signif-
icance. Thus, our findings in a clinical population lend support to their
hypothesis that ethanol exposure that ends with sufficient time to be
completely metabolized may have a preconditioning effect on infarct
size, whereas ethanol exposure that persists close to the time of
infarction does not.
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Patient Management
Guided by Viability Imaging
We read with interest the study by Siebelink et al. (1) comparing
positron emission tomography (PET) and single-photon emission
computed tomographic imaging (SPECT)-guided patient man-
agement. The investigators are to be commended for undertaking
this difficult study. However, there are important limitations that
may limit the conclusions drawn.
Patient population. The greatest impact of viability imaging is in
patients with severe left ventricular (LV) dysfunction (2,3). Such
patients are at high risk for events but have the most to gain from
revascularization when significant viable myocardium is detected
(2–4). In the Siebelink et al. study (1), the majority of the patients
(65%) had only mild to moderate LV dysfunction. Thus, it is not
surprising that the overall event rate was low. This low event rate
with the small sample size makes it unlikely that any difference
between the two strategies would be identified.
There was no information regarding angina or prior stress
perfusion imaging, both of which could lead to preselection bias
and could influence decisions for revascularization (even after
viability data are available). All of the patients had preceding
angiograms, which likely biases therapy toward revascularization.
The time from randomization to revascularization was lengthy
(estimated at 115 vs. 132 days). Previous studies have shown that
long waits to revascularization can lead to high mortality rates in
patients with severe LV dysfunction (4). In the Siebelink et al. (1)
study, there were two deaths (2%) awaiting revascularization,
further suggesting that the study population represented a rela-
tively lower-risk group of patients. Furthermore, some of the
benefits of revascularization may have been lost because of the
revascularization delay (4).
Viability imaging. Severe 2-methoxy isobutyl isonitrile (MIBI)
perfusion defects can have viable myocardium by fluorodeoxyglu-
cose (FDG) (5–7). The investigators observed 20% nonviable
myocardium by MIBI and 16% by FDG. A focus on more severe
LV dysfunction would have increased the number of severe defects
and the discrepancies with FDG as observed by others (5–7).
Defects with greater than 50% MIBI uptake were called
“jeopardized.” For ammonia/FDG, only mismatch was considered
“jeopardized.” Recent data indicate that the degree of FDG uptake
relates to the degree of recovery of function (8,9). The use of 50%
cutoff for FDG has been beneficial in directing revascularization
(10). In the current study, it would appear that a fixed defect with
65% MIBI uptake would be considered jeopardized, but 65%
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